Literature DB >> 25406216

Gemella morbillorum prosthetic aortic valve endocarditis.

Lokesh Shahani1.   

Abstract

Gemella morbillorum is facultative anaerobic, Gram-positive cocci and are a commensal part of human flora. The reported patient in this case, with a prosthetic bovine aortic valve, presented with fever, poor dental hygiene, new cardiac murmur and signs of congestive heart failure. Blood cultures were positive for a viridans streptococcal species; however, the organism could not be further identified at our institution. Echocardiogram demonstrated a decrease in ejection fraction and vegetation attached to the prosthetic aortic valve associated with a perivalvular abscess. The patient was treated with a 6-week regimen of penicillin G with gentamicin for the first 2 weeks along with cardiac surgery. The results from the 16S rRNA gene sequencing of the viridans streptococcal species were available, which reported the organism as G. morbillorum. This case adds to the literature on G. morbillorum prosthetic valve endocarditis and provides additional evidence to consider infectious endocarditis in the setting of G. morbillorum bacteraemia. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25406216      PMCID: PMC4244371          DOI: 10.1136/bcr-2014-207304

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Gemella bacteraemia characterised by 16S ribosomal RNA gene sequencing.

Authors:  P C Y Woo; S K P Lau; A M Y Fung; S K Chiu; R W H Yung; K Y Yuen
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

2.  Gemella morbillorum prosthetic valve endocarditis.

Authors:  J Holland; R Wilson; N Cumpston
Journal:  N Z Med J       Date:  1996-09-27

3.  Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert
Journal:  Circulation       Date:  2005-06-14       Impact factor: 29.690

4.  Gemella morbillorum prosthetic valve endocarditis.

Authors:  M Obadah Al Chekakie; Alain Heroux; Michelle Montpetit; Hassan Nemeh
Journal:  Congest Heart Fail       Date:  2009 Nov-Dec

Review 5.  Mitral bioprosthetic valve endocarditis caused by an unusual microorganism, Gemella morbillorum, in an intravenous drug user.

Authors:  Ramzan M Zakir; Anthony Al-Dehneh; Leticia Dabu; Raj Kapila; Muhamed Saric
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

6.  Mechanical valve endocarditis caused by Gemella morbillorum.

Authors:  Ghanem Al-Hujailan; Philippe Lagacé-Wiens
Journal:  J Med Microbiol       Date:  2007-12       Impact factor: 2.472

  6 in total
  3 in total

1.  Gemella morbillorum isolated from a pelvic abscess in an HIV-positive patient with squamous cell carcinoma of the perianal region.

Authors:  Benjamin Edward Ueberroth; Renato Roxas
Journal:  BMJ Case Rep       Date:  2019-05-24

2.  Gemella morbillorum endocarditis of pulmonary valve:a case report.

Authors:  Dan Li; Zhicheng Zhu; Xiaomei Zheng; Weitie Wang; Rihao Xu; Kexiang Liu
Journal:  J Cardiothorac Surg       Date:  2017-03-23       Impact factor: 1.637

3.  Risk Factors and Patient Profile of Infective Endocarditis due to Gemella spp.

Authors:  Pramod Theetha Kariyanna; Bayu Sutarjono; Naga Pranavi Ellanti; Apoorva Jayarangaiah; Amog Jayarangaiah; Harshith Priyan Chandrakumar; Ashkan Tadayoni; Moro O Salifu; Isabel M McFarlane
Journal:  Am J Med Case Rep       Date:  2020-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.